Internetiühendust pole — kuvatakse lehe salvestatud versioon.

DBV Technologies

USUSD
← Aktsiafiltri juurde
US:DBVTFLSE:0QAJPA:DBV

DBV Technologies (PA:DBV) — Biotechnology: Biological Products (No Diagnostic Substances). Börside arv, kus ettevõtte aktsiatega kaubeldakse: 3. Sellel lehel — hind ja graafik, dividendid, suurimad aktsionärid ja aktsiate arvu ajalugu.

Ettevõtte kohta

Veebileht
dbv-technologies.com
Investorite suhted
dbv-technologies.com/investor-overview/
Sektor
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Peakontor
CHATILLON, France
Tegevjuht
Daniel Tassé
Töötajad
170
Asutatud
2002
Ringluses olevad aktsiad
296.06 mln seisuga 2026-07-16
Vabalt kaubeldavad aktsiad
34.94 mln
Turukapitalisatsioon
731.56 mln USD
Siseringi isikud
0%
Institutsionaalsed investorid
41.66%
Tegevusala (SIC)
Biological Products, (No Diagnostic Substances)
Õiguslik vorm
K65D
ISIN
FR0010417345
LEI
969500PVBQFWQKVDMD80
FCF
−171 mln USD
Võlg
510 tuh USD
netoraha
Kasum ja FCF — 12 kuu jooksul kuni 30.06.2026 (ettevõtte viimane raport).
Kirjeldus

DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France. Its product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed Phase 3 clinical trial for the treatment of peanut allergies; and Viaskin Milk which is in Phase 1/2 clinical trial for the treatment of immunoglobulin E (IgE) mediated or cow's milk protein allergy and eosinophilic esophagitis. The company's earlier stage research programs include celiac disease. In addition, the company develops Viaskin technology platform, a platform to potentially treat food allergy. It has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Châtillon, France.

Börsid ja tikkerid

BörsTikkerValuutaHindTüüp
US USA StocksDBVTF OTCUSD1.98 -10.00%tavalised aktsiad
LSE London Stock Exchange0QAJ IOBEUR1.695 +0.12%tavalised aktsiad
PA Euronext ParisDBV põhinoteeringEUR1.678 -0.65%tavalised aktsiad

Hind 3 kuu jooksul

3M1Y3Y5Y
tõususepäev langusepäevViige kursor / puudutage päeva — avamis-, sulgemis-, kõrgeim ja madalaim hind

Selle nädala uudised

Ettevõtte veebisaidilt uudiseid veel pole.

reklaam

Suurimad omanikud

OmanikOsalusAktsiadAruande kuupäev
MPM Bioimpact LLC5.83%3.67 mln2026-06-30
Siren, L.L.C.2.95%1.86 mln2026-06-30
Vivo Capital, LLC2.93%1.84 mln2026-06-30
Perceptive Advisors Llc2.63%1.65 mln2026-06-30
Baker Bros. Advisors, LP2.32%1.46 mln2026-06-30
Artisan Partners Limited…2.18%1.37 mln2026-06-30
UBS Group AG2.09%1.31 mln2026-06-30
Morgan Stanley1.52%954 9082026-06-30
Logos Global Management…1.46%915 0002026-06-30
Patient Square Capital L…1.45%909 4742026-06-30
Artisan Partners Funds I…1.34%840 2512026-06-30
Fidelity Advisor Series…0.68%428 8002026-07-31
iShares Trust-iShares Co…0.3%942 5282026-08-31
MOHIDEEN PHARIS (Officer…≈0.23%144 9952026-01-29
iShares Trust-iShares MS…0.21%666 4802026-08-31
Ikarian Capital, LLC0.19%525 0002025-12-31
RUSSELL INVESTMENT CO-Ta…0.07%45 0892026-04-30
College Retirement Equit…0.04%117 6682026-06-30
RUSSELL INVESTMENT CO-U.…0.04%22 7072026-04-30
Fidelity Salem Street Tr…0.03%108 0802026-07-31
SPDR INDEX SHARES Fd.S-S…0.03%105 2332026-07-31
Fidelity Concord Street…0.02%51 0822026-07-31
Fidelity Concord Street…0.02%12 8552026-07-31
iShares Trust-iShares Co…0.01%41 1822026-08-31
SPDR-EUROPE-SSgA SPDR ET…0.01%36 6502026-07-31
SPDR-EUROPE-SSgA SPDR ET…0.01%28 8542026-07-31
iShares Trust-iShares MS…0.01%19 5272026-08-31
RUSSELL INVESTMENT FUNDS…0.01%5 8342026-06-30
Steward Funds Inc-Stewar…0.01%4 0512026-04-30
LORD ABBETT SECURITIES T…0%2 9732026-04-30
Trust for Professional M…0%2 2452026-05-31
Gabelli Healthcare & Wel…0%4002026-06-30